Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomised Controlled Trial

被引：1

作者：

Huddart, Robert ^{[1
,2
]}

Hafeez, Shaista ^{[1
,2
]}

Griffin, Clare ^{[1
]}

Choudhury, Ananya ^{[3
]}

Foroudi, Farshad ^{[4
]}

Syndikus, Isabel ^{[5
]}

Hindson, Benjamin ^{[6
]}

Webster, Amanda ^{[7
,8
]}

Mcnair, Helen ^{[1
,2
]}

Birtle, Alison ^{[9
,10
,11
]}

Varughese, Mohini ^{[12
]}

Henry, Ann ^{[13
,14
]}

Mclaren, Duncan ^{[15
]}

Parikh, Omi ^{[9
]}

Nikapota, Ashok ^{[16
]}

Tang, Colin ^{[17
]}

Patel, Emma ^{[18
]}

Miles, Elizabeth ^{[18
]}

Warren-Oseni, Karole ^{[1
,2
]}

Kron, Tomas ^{[19
]}

Hill, Courtney ^{[20
]}

Philipps, Lara ^{[1
]}

Vassallo-Bonner, Catalina ^{[1
]}

Cheung, Ka Ching ^{[1
]}

Gribble, Hannah ^{[1
]}

Lewis, Rebecca ^{[1
]}

Hall, Emma ^{[1
]}

机构：

[1] Inst Canc Res, Sutton, England

[2] Royal Marsden NHS Fdn Trust, Sutton, England

[3] Christie NHS Fdn Trust, Manchester, England

[4] Austin Hlth, Heidelberg, Vic, Australia

[5] Clatterbridge Canc Ctr, Bebington, England

[6] Christchurch Hosp, Canterbury Reg Canc & Haematol Serv, Christchurch, New Zealand

[7] Univ Coll Hosp, London, England

[8] Univ Coll Hosp, Univ Coll Hosp NHS Fdn Trust, London, England

[9] Lancashire Teaching Hosp NHS Fdn Trust, Royal Preston Hosp, Rosemere Canc Ctr, Preston PR2 9HT, Lancs, England

[10] Univ Manchester, Manchester, England

[11] Univ Cent Lancashire, Preston, England

[12] Royal Devon & Exeter NHS Fdn Trust, Royal Devon & Exeter Hosp, Exeter, England

[13] Univ Leeds, Leeds, England

[14] St James Univ Hosp, Leeds Teaching Hosp NHS Trust, Leeds, England

[15] Western Gen Hosp, NHS Lothian, Edinburgh, Scotland

[16] Royal Sussex Cty Hosp, Brighton & Sussex Univ Hosp NHS Trust, Brighton, England

[17] Sir Charles Gairdner Hosp, Nedlands, WA, Australia

[18] Mt Vernon Hosp, Natl Radiotherapy Trials Qual Assurance Grp RTTQA, Northwood, England

[19] Peter Maallum Canc Ctr, Melbourne, Vic, Australia

[20] TROG Canc Res, Waratah, NSW, Australia

来源：

EUROPEAN UROLOGY | 2025年 / 87卷 / 01期

关键词：

Adaptive radiotherapy; Image-guided radiotherapy; Radiotherapy; Randomised controlled trial; LONG-TERM OUTCOMES; GASTROINTESTINAL SYMPTOMS; RADIATION-THERAPY; QUESTIONNAIRE; VOLUME;

D O I：

10.1016/j.eururo.2024.09.006

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Background and objective: Delivering radiotherapy to the bladder is challenging as it is a mobile, deformable structure. Dose-escalated adaptive image-guided radiotherapy could improve outcomes. RAIDER aimed to demonstrate the safety of such a schedule. Methods: RAIDER is an international phase 2 noncomparative randomised controlled trial (ISRCTN26779187). Patients with unifocal T2-T4a urothelial bladder cancer were randomised (1:1:2) to standard whole bladder radiotherapy (WBRT), standard-dose adaptive radiotherapy (SART), or dose-escalated adaptive radiotherapy (DART). Two fractionation (f) schedules recruited independently. WBRT and SART dose was 55 Gy/20f or 64 Gy/32f, and DART dose was 60 Gy/20f or 70 Gy/32f. For SART and DART, a radiotherapy plan (small, medium, or large) was chosen daily. The primary endpoint was the proportion of patients with radiotherapy-related late Common Terminology Criteria for Adverse Events grade >= 3 toxicity; the trial was designed to rule Key findings and limitations: A total of 345 patients were randomised between October 2015 and April 2020: 41/46 WBRT, 41/46 SART, and 81/90 DART patients in the 20f/32f

引用

页码：60 / 70

页数：11

共 50 条

[1] Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER)
Hafeez, S.
Lewis, R.
Hall, E.
Huddart, R.
CLINICAL ONCOLOGY, 2021, 33 (06) : E251 - E256
[2] Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance
Hafeez, Shaista
Webster, Amanda
Hansen, Vibeke N.
McNair, Helen A.
Warren-Oseni, Karole
Patel, Emma
Choudhury, Ananya
Creswell, Joanne
Foroudi, Farshad
Henry, Ann
Kron, Tomas
McLaren, Duncan B.
Mitra, Anita, V
Mostafid, Hugh
Saunders, Daniel
Miles, Elizabeth
Griffin, Clare
Lewis, Rebecca
Hall, Emma
Huddart, Robert
BMJ OPEN, 2020, 10 (12):
[3] Randomised controlled trial for dose-escalated radiotherapy in locally advanced rectal cancer
Couwenberg, A.
Verkooijen, H. M.
Berbee, M.
Burbach, J. P. M.
Hoendervangers, S.
Reerink, O.
Philippens, M. E. P.
Consten, E. C. J.
Smits, A. B.
Heikens, J.
Wijffels, N.
Schiphorst, A.
Lacle, M. M.
Wessels, F. J.
Koopman, M.
Van Grevenstein, W. M. U.
Intven, M. P. W.
RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S191 - S191
[4] DOSE-ESCALATED BLADDER RADIOTHERAPY: EARLY CLINICAL RESULTS
McDonald, F.
Lalondrelle, S.
Harris, V.
Taylor, H.
Warren-Oseni, K.
Hansen, V.
Jones, K.
Khoo, V.
Huddart, R.
RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S442 - S443
[5] Re: Robert Huddart, Shaista Hafeez, Clare Griffin, et al. Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomized Controlled Trial. Eur Urol 2025;87:60-70
Davis, Laura E.
Calaway, Adam
Shoag, Jonathan
EUROPEAN UROLOGY, 2025, 87 (04) : e73 - e74
[6] Radiotherapy for muscle-invasive carcinoma of the bladder: Results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy
Cowan, RA
McBain, CA
Ryder, WDJ
Wylie, JP
Logue, JP
Turner, SL
Van Der Voet, J
Collins, CD
Khoo, VS
Read, GR
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (01): : 197 - 207
[7] Phase I dose-escalated image-guided adaptive bladder radiotherapy study: Results of first dose cohort (68Gy).
Huddart, Robert
McDonald, Fiona
Hafeez, Shaista
Warren-Oseni, Karole
Taylor, Helen
Thompson, Alan
Khoo, Vincent
Harris, Victoria
McNair, Helen
Mohammed, Kabir
Thomas, Karen
Jones, Kelly
Dearnaley, David Paul
Horwich, Alan
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
[8] Efficacy of Dose-Escalated Radiotherapy for Recurrent Colorectal Cancer
Jo, Sunmi
Choi, Yunseon
Park, Sung-Kwang
Kim, Jin-Young
Kim, Hyun Jung
Lee, Yun-Han
Oh, Won Yong
Cho, Heunglae
Ahn, Ki Jung
ANNALS OF COLOPROCTOLOGY, 2016, 32 (02) : 66 - 72
[9] Dose-Escalated Radiotherapy for Prostate Cancer Is the Sky the Limit?
Gray, Phillip J.
Zietman, Anthony L.
JAMA ONCOLOGY, 2015, 1 (07) : 883 - 884
[10] Dose-escalated radiotherapy in esophageal cancer: A review of the literature
Boustani, J.
Crehange, G.
CANCER RADIOTHERAPIE, 2022, 26 (6-7): : 884 - 889

← 1 2 3 4 5 →